Brooklyn Investment Group Purchases 365 Shares of HCA Healthcare, Inc. $HCA

Brooklyn Investment Group increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 32.5% during the 1st quarter, Holdings Channel reports. The firm owned 1,489 shares of the company’s stock after acquiring an additional 365 shares during the period. Brooklyn Investment Group’s holdings in HCA Healthcare were worth $514,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of HCA. Avantax Advisory Services Inc. grew its stake in shares of HCA Healthcare by 0.4% in the 1st quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after buying an additional 32 shares in the last quarter. Horizon Investments LLC boosted its position in HCA Healthcare by 1.1% in the 1st quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock valued at $1,097,000 after buying an additional 33 shares during the period. Catalyst Financial Partners LLC raised its holdings in shares of HCA Healthcare by 4.3% in the 1st quarter. Catalyst Financial Partners LLC now owns 872 shares of the company’s stock valued at $301,000 after purchasing an additional 36 shares in the last quarter. Moors & Cabot Inc. raised its holdings in shares of HCA Healthcare by 4.8% in the 1st quarter. Moors & Cabot Inc. now owns 858 shares of the company’s stock valued at $297,000 after purchasing an additional 39 shares in the last quarter. Finally, Perigon Wealth Management LLC raised its holdings in shares of HCA Healthcare by 2.3% in the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company’s stock valued at $621,000 after purchasing an additional 40 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Down 0.5%

HCA stock opened at $393.86 on Tuesday. The company has a fifty day moving average price of $370.95 and a 200 day moving average price of $352.19. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a market cap of $92.16 billion, a price-to-earnings ratio of 16.56, a price-to-earnings-growth ratio of 1.24 and a beta of 1.39. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.50 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare’s payout ratio is currently 12.11%.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Wells Fargo & Company reduced their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating for the company in a research note on Thursday, August 14th. Wall Street Zen upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. Bank of America lowered shares of HCA Healthcare from a “buy” rating to a “neutral” rating and set a $394.00 price objective on the stock. in a research note on Wednesday, July 16th. Barclays lowered their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating on the stock in a report on Monday, July 28th. Finally, Stephens upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Nine research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $398.58.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.